Head to Head Analysis: American Vanguard Corporation (AVD) vs. Marrone Bio Innovations (MBII)
American Vanguard Corporation (NYSE: AVD) and Marrone Bio Innovations (NASDAQ:MBII) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitabiliy and institutional ownership.
Valuation & Earnings
This table compares American Vanguard Corporation and Marrone Bio Innovations’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|American Vanguard Corporation||$318.49 million||1.91||$44.28 million||$0.50||40.90|
|Marrone Bio Innovations||$15.53 million||2.42||-$19.96 million||N/A||N/A|
American Vanguard Corporation has higher revenue and earnings than Marrone Bio Innovations.
Insider and Institutional Ownership
76.5% of American Vanguard Corporation shares are held by institutional investors. Comparatively, 29.5% of Marrone Bio Innovations shares are held by institutional investors. 4.7% of American Vanguard Corporation shares are held by company insiders. Comparatively, 7.3% of Marrone Bio Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Risk & Volatility
American Vanguard Corporation has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Marrone Bio Innovations has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500.
American Vanguard Corporation pays an annual dividend of $0.06 per share and has a dividend yield of 0.3%. Marrone Bio Innovations does not pay a dividend. American Vanguard Corporation pays out 12.0% of its earnings in the form of a dividend.
This is a breakdown of current ratings and recommmendations for American Vanguard Corporation and Marrone Bio Innovations, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|American Vanguard Corporation||0||1||1||1||3.00|
|Marrone Bio Innovations||0||2||1||0||2.33|
American Vanguard Corporation currently has a consensus target price of $19.50, suggesting a potential downside of 4.65%. Marrone Bio Innovations has a consensus target price of $1.75, suggesting a potential upside of 45.83%. Given Marrone Bio Innovations’ higher possible upside, analysts clearly believe Marrone Bio Innovations is more favorable than American Vanguard Corporation.
This table compares American Vanguard Corporation and Marrone Bio Innovations’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|American Vanguard Corporation||4.56%||5.10%||3.34%|
|Marrone Bio Innovations||-189.32%||N/A||-59.64%|
American Vanguard Corporation beats Marrone Bio Innovations on 10 of the 14 factors compared between the two stocks.
American Vanguard Corporation Company Profile
American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V. (AMVAC CV), AMVAC Netherlands BV (AMVAC BV), Envance Technologies, LLC (Envance), AMVAC Singapore Pte, Ltd (AMVAC Sgpr) and Huifeng AMVAC Innovation Co. Limited (Hong Kong JV). AMVAC is a specialty chemical manufacturer that develops and markets products for agricultural, commercial and consumer uses. It manufactures and formulates chemicals, such as insecticides, fungicides, herbicides, molluscicides and soil fumigants for crops, turf and ornamental plants, and human and animal health protection.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
Receive News & Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related companies with MarketBeat.com's FREE daily email newsletter.